Ann Daugherty, PhD
Ann Daugherty, PhD, currently focuses on identifying and accessing promising external drug delivery technologies in addition to developing internal long-acting delivery technologies for ocular and CNS delivery of macromolecules for Genentech’s portfolio molecules. Dr Daugherty has over 40 publications on drug delivery, 6 issued US patents, is an invited speaker at various national and international conferences and a co-chair of several drug delivery conferences, notably PODD, Drug Delivery Partnerships and Drug Delivery West. Dr Daugherty serves as a reviewer for several journals, including the J. Controlled Release, was a co-editor of a special issue on Ocular Drug Design and Delivery in Drug Discovery Today and was elected to be a Fellow of the Controlled Release Society.
